MNG
CVS icon

Manning & Napier Group’s CVS Health CVS Stock Holding History

Manning & Napier Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$16.7M Sell
209,719
-277,263
-57% -$21.2M 0.19% 97
2023
Q4 		$38.5M Sell
486,982
-38,258
-7% -$2.72M 0.46% 61
2023
Q3 		$36.7M Buy
525,240
+25,779
+5% +$1.83M 0.45% 59
2023
Q2 		$34.5M Buy
499,461
+272,721
+120% +$19.4M 0.39% 72
2023
Q1 		$16.8M Buy
226,740
+814
+0.4% +$68.3K 0.2% 111
2022
Q4 		$21.1M Sell
225,926
-3,144
-1% -$303K 0.26% 93
2022
Q3 		$21.8M Sell
229,070
-10,498
-4% -$1.04M 0.29% 93
2022
Q2 		$22.2M Buy
+239,568
New +$23.4M 0.26% 94
2020
Q2 		– Sell
-34,067
Closed -$2.02M – 285
2020
Q1 		$2.02M Sell
34,067
-367,553
-92% -$24.5M 0.02% 246
2019
Q4 		$29.8M Buy
401,620
+34,792
+9% +$2.44M 0.32% 80
2019
Q3 		$23.1M Buy
366,828
+2,940
+0.8% +$174K 0.26% 96
2019
Q2 		$19.8M Buy
363,888
+63,925
+21% +$3.44M 0.22% 102
2019
Q1 		$16.2M Buy
299,963
+67,558
+29% +$4.17M 0.18% 108
2018
Q4 		$15.2M Buy
232,405
+20,134
+9% +$1.5M 0.19% 106
2018
Q3 		$16.7M Buy
212,271
+16,031
+8% +$1.15M 0.16% 104
2018
Q2 		$12.6M Buy
196,240
+4,199
+2% +$277K 0.12% 115
2018
Q1 		$11.9M Buy
192,041
+46,659
+32% +$3.35M 0.12% 118
2017
Q4 		$10.5M Buy
+145,382
New +$10.6M 0.09% 115

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Manning & Napier Group's CVS Position: Q1 2024 in Review

Manning & Napier Group reduced its CVS Health (CVS) stake by 57% in Q1 2024, selling an estimated $21.2M and leaving 209,719 shares worth $16.7M. The position accounts for 0.19% of the portfolio, ranked #97.

Manning & Napier Group first reported a position in CVS in Q4 2017 and has held it in 18 quarters since. The position peaked at $38.5M in Q4 2023. 2,182 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Manning & Napier Group held 209,719 shares of CVS Health worth $16.7M as of Q1 2024.
  • Manning & Napier Group sold 277,263 CVS Health shares in Q1 2024, an estimated $21.2M.
  • CVS Health made up 0.19% of Manning & Napier Group's portfolio in Q1 2024, its #97 holding.
  • Manning & Napier Group first reported a position in CVS Health in Q4 2017 and has held it in 18 quarters since.
  • Manning & Napier Group's CVS Health position peaked at $38.5M in Q4 2023.
  • 2,182 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Manning & Napier Group's 13F filing for Q1 2024, filed 15 Apr 2024.